TWiPO #89: Spotlight on Immunotherapy for Pediatrics - Natural Killer T-Cells with Dr. Andras Heczey

WATCH THE VIDEO WEBCAST HERE: https://www.youtube.com/watch?v=nJZYz1XrsyY
Hosts, Dr. Timothy Cripe and Dr. Brenda Weigel, are joined in this episode by Dr. Andras Heczey from Texas Children's Hospital/Baylor College of Medicine. Listen in as they discuss Dr. Heczey's expertise & research in utilizing Natural Killer (NK) T-cells for pediatric immunotherapy treatment and the process of doing so.
Have any thoughts? Questions? Ideas for future topics? Email us at TWIPO@solvingkidscancer.org.
Subscribe to TWIPO to get notifications of new uploads.
Want to listen to TWIPO's past episodes? Visit www.solvingkidscancer.org/podcast

TWiPO #67 - Interview with Dr. Mitchell Cairo

Hosts Dr. Nilay Shah, Dr. Ryan Roberts, and Dr. Keri Streby from Nationwide Children’s Hospital in Columbus, Ohio, sit down with Dr. Mitchell Cairo to discuss his experiences within the pediatric cancer research sector.

TWiPO #13 ~ Updates, epidemiology of CNS tumors, birth order, and cell phone risks

August
19, 2011
Host Dr. Tim Cripe and co-hosts Dr. Lionel Chow
and Dr. Jim Geller discuss updates to previous TWiPO episodes reporting on
recent press coverage and publications of BiTE antibodies and modified T-cell
approaches, and then discuss recent studies on birth defects, birth order, and
cell phone use and possible link to risk of childhood cancers.
N Engl J Med. 2011 Aug 10. Chimeric Antigen Receptor-Modified T Cells in Chronic
Lymphoid Leukemia.
Sci Transl Med 10 August 2011: T Cells with Chimeric Antigen Receptors Have Potent Antitumor Effects and
Can Establish Memory in Patients with Advanced Leukemia;
Vol. 3, Issue 95, p. 95ra73
7:40 Decitabine upregulation of NY-ESO-1 and
MAGE family expression in NB. MAGE-A1, MAGE-A3, and NY-ESO-1 can be upregulated on neuroblastoma cells
to facilitate cytotoxic-T lymphocyte-mediated tumor cell killing,
K Lucas
9:50 Discussion of Rosenberg paper on
immunotherapy in solid tumors; Nat Rev Clin Oncol. 2011 Aug 2. doi:
10.1038/nrclinonc.2011.116. Cell transfer immunotherapy for
metastatic solid cancer-what clinicians need to know.
Rosenberg SA
13:00 Birth anomolies in CNS pediatric tumors
29:00 Absolute risk is small; will this lead to
genome-wide association studies?
31:51 Birth order and risk of
pediatric cancers
42:30 Mobile phone use and incidence
of pediatric CNS tumors.
46:47 Listener question about time elapse of
planning clinical trials to opening.
Please send any comments or questions to
twipo@solvingkidscancer.org